Association of discontinuation of cardiovascular therapies with the risk of in-hospital death in patients with COVID-19, with prehospital exposure to the treatment of interest.</p
Introduction The coronavirus disease 2019 (COVID-19) pandemic is the largest public health challeng...
Contrasting data have been published about the impact of cardiovascular disease on Covid-19. A compr...
The coronavirus disease 2019 (COVID-19) pandemic has consumed our healthcare system, with immediate ...
Association of initiation of cardiovascular therapies with the risk of in-hospital death in patients...
Association of in-hospital use of cardiovascular therapies with the risk of in-hospital death in pat...
Association of prehospital cardiovascular therapy exposure with the risk of in-hospital death in pat...
To assess the associations of exposure and modifications in exposure (i.e., discontinuation on admis...
Cardiovascular diseases (CVDs) remain the leading cause of death worldwide and significantly affect ...
Odds ratios with 95% confidence intervals for in-hospital death for prehospital use (vs. no prehospi...
While hospital admissions for myocardial infarction (MI) and pulmonary embolism (PE) are decreased d...
While hospital admissions for myocardial infarction (MI) and pulmonary embolism (PE) are decreased d...
Background: The coronavirus disease 19 (COVID-19) recently became one of the leading causes of death...
BACKGROUND: The prescription of recommended medical therapies is a key factor to improve prognosis a...
Sudden cardiac death is commonly seen due to arrhythmias, which is a common cardiac manifestation se...
History of cardiovascular diseases (CVDs) may influence the prognosis of patients hospitalised for C...
Introduction The coronavirus disease 2019 (COVID-19) pandemic is the largest public health challeng...
Contrasting data have been published about the impact of cardiovascular disease on Covid-19. A compr...
The coronavirus disease 2019 (COVID-19) pandemic has consumed our healthcare system, with immediate ...
Association of initiation of cardiovascular therapies with the risk of in-hospital death in patients...
Association of in-hospital use of cardiovascular therapies with the risk of in-hospital death in pat...
Association of prehospital cardiovascular therapy exposure with the risk of in-hospital death in pat...
To assess the associations of exposure and modifications in exposure (i.e., discontinuation on admis...
Cardiovascular diseases (CVDs) remain the leading cause of death worldwide and significantly affect ...
Odds ratios with 95% confidence intervals for in-hospital death for prehospital use (vs. no prehospi...
While hospital admissions for myocardial infarction (MI) and pulmonary embolism (PE) are decreased d...
While hospital admissions for myocardial infarction (MI) and pulmonary embolism (PE) are decreased d...
Background: The coronavirus disease 19 (COVID-19) recently became one of the leading causes of death...
BACKGROUND: The prescription of recommended medical therapies is a key factor to improve prognosis a...
Sudden cardiac death is commonly seen due to arrhythmias, which is a common cardiac manifestation se...
History of cardiovascular diseases (CVDs) may influence the prognosis of patients hospitalised for C...
Introduction The coronavirus disease 2019 (COVID-19) pandemic is the largest public health challeng...
Contrasting data have been published about the impact of cardiovascular disease on Covid-19. A compr...
The coronavirus disease 2019 (COVID-19) pandemic has consumed our healthcare system, with immediate ...